tradingkey.logo
tradingkey.logo
Suchen

Liminatus Pharma Ord Shs Class A

LIMN
Zur Watchlist hinzufügen
0.110USD
+0.003+2.70%
Handelsschluss 06/30, 16:00ETKurse um 15 Minuten verzögert
4.82MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Unternehmen

Liminatus Pharma Ord Shs Class A Informationen

Börsenkürzel- -
Name des Unternehmens- -
IPO-datum- -
CEO- -
Anzahl der mitarbeiter- -
Wertpapierart- -
Geschäftsjahresende- -
Addresse- -
Stadt- -
Börse- -
Land- -
Postleitzahl- -
Telefon- -
Website- -
Börsenkürzel- -
IPO-datum- -
CEO- -

Führungskräfte von Liminatus Pharma Ord Shs Class A

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
16.67K
--
Mr. Rohit Nanani
Mr. Rohit Nanani
Director
Director
--
--
Mr. Chris Kim
Mr. Chris Kim
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Eun Sook Lee, M.D., Ph.D.
Dr. Eun Sook Lee, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Ji Yeon Baek
Ms. Ji Yeon Baek
Independent Director
Independent Director
--
--
Mr. Scott Dam
Mr. Scott Dam
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Sang-jin Daniel Lee
Mr. Sang-jin Daniel Lee
Head - Research & Development
Head - Research & Development
--
--
Dr. Byong C. Yoo, Ph.D.
Dr. Byong C. Yoo, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Mr. Beom K. Choi
Mr. Beom K. Choi
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Philip Lemons
Mr. Philip Lemons
Director
Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
16.67K
--
Mr. Rohit Nanani
Mr. Rohit Nanani
Director
Director
--
--
Mr. Chris Kim
Mr. Chris Kim
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Eun Sook Lee, M.D., Ph.D.
Dr. Eun Sook Lee, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Ji Yeon Baek
Ms. Ji Yeon Baek
Independent Director
Independent Director
--
--
Mr. Scott Dam
Mr. Scott Dam
Chief Financial Officer
Chief Financial Officer
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Liminatus Pharma Ord Shs Class A?

Die fünf größten Anteilseigner von Liminatus Pharma Ord Shs Class A sind: Mr. Nicholas Fernandez
KeyAI